GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Other Net Income (Loss)

Tauns Laboratories (TSE:197A) Other Net Income (Loss) : 円0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Other Net Income (Loss)?

Tauns Laboratories's Other Net Income (Loss) for the three months ended in Dec. 2024 was 円0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was 円0 Mil.

Tauns Laboratories's annual Other Net Income (Loss) stayed the same from Jun. 2022 (円0 Mil) to Jun. 2023 (円0 Mil) but then increased from Jun. 2023 (円0 Mil) to Jun. 2024 (円0 Mil).


Tauns Laboratories Other Net Income (Loss) Historical Data

The historical data trend for Tauns Laboratories's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Other Net Income (Loss) Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
Other Net Income (Loss)
- - -

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24
Other Net Income (Loss) - - - - -

Tauns Laboratories Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tauns Laboratories Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines